| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000036141 |
| Receipt No. | R000041171 |
| Scientific Title | Effects on postprandial blood glucose and triglyceride levels of confectionery made using Naked barley grown in Ehime prefecture for healthy subjects: crossover, placebo controlled randomized clinical trial |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2019/06/12 (Ver. 2) |
| Basic information | ||
| Public title | Effects on postprandial blood glucose and triglyceride levels of confectionery made using Naked barley grown in Ehime prefecture for healthy subjects: crossover, placebo controlled randomized clinical trial | |
| Acronym | Effects on postprandial blood glucose triglyceride levels of confectionery made using Naked barley grown for healthy subjects: randomized clinical trial | |
| Scientific Title | Effects on postprandial blood glucose and triglyceride levels of confectionery made using Naked barley grown in Ehime prefecture for healthy subjects: crossover, placebo controlled randomized clinical trial | |
| Scientific Title:Acronym | Effects on postprandial blood glucose triglyceride levels of confectionery made using Naked barley grown for healthy subjects: randomized clinical trial | |
| Region |
|
|
| Condition | |||
| Condition | Postprandial blood glucose and triglyceride levels | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The objective of this study is to examine the effects on postprandial blood glucose and triglyceride levels of confectionery made using Naked barley grown in Ehime prefecture compared with confectionery without Naked barley for healthy subjects by crossover, placebo controlled randomized clinical trial |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Postprandial blood glucose and triglyceride levels, and their area under the curve |
| Key secondary outcomes | 1.Postprandial blood insulin level, and its area under the curve
2.Subjective appetite change after test meals 3. Gastrointestinal symptoms after test meals |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Firstly, the participants eat the test meal (bread 25g and butter 10g).
After eating test meal, the participants subsequently eat confectionery made using Naked barley (102g) in the intervention group. |
|
| Interventions/Control_2 | Firstly, the participants eat the test meal (bread 25g and butter 10g).
After eating test meal, the participants subsequently eat placebo confectionery made using wheat (95g) in the control group. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy men and women of 20 to 69 years of age at entry | |||
| Key exclusion criteria | 1. Body mass index less than 18.5 kg / m 2, or, over 30 kg / m 2
2. Persons undergoing treatment for hypertension, dyslipidemia, diabetes, cancer, ischemic heart disease, cerebrovascular disease, chronic kidney disease, dementia, severe digestive system diseases 3. Women during pregnancy or lactation period 4. Food allergy of food to be provided (wheat, barley, peanuts, eggs) 5. The physician consider the individuals as inappropriate. |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Ehime University | ||||||
| Division name | Laboratory of Community Health and Nutrition, Special Course of Food and Health Science Department of Bioscience, Graduate School of Agriculture | ||||||
| Zip code | |||||||
| Address | 3-5-7 Tarumi, Matsuyama, Ehime | ||||||
| TEL | 089-946-9960 | ||||||
| maruyama.kotatsu.rt@ehime-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Ehime University | ||||||
| Division name | Laboratory of Community Health and Nutrition, Special Course of Food and Health Science Department o | ||||||
| Zip code | |||||||
| Address | 3-5-7 Tarumi, Matsuyama, Ehime | ||||||
| TEL | 089-946-9960 | ||||||
| Homepage URL | |||||||
| maruyama.kotatsu.rt@ehime-u.ac.jp | |||||||
| Sponsor | |
| Institute | Ehime University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041171 |